A Study of Ramosetron Plus DX, Dexamethasone, Compared to Granisetron Plus DX for the Prevention of Vomiting and Nausea

Phase 3 Completed 287 enrolled Astellas Pharma Inc Astellas Pharma Taiwan, Inc. · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the efficacy and safety of ramosetron plus dexamethasone injection with granisetron plus dexamethasone injection for the prevention of chemotherapy-induced vomiting and nausea.

Timeline

Start: 2006-01
Primary completion: 2007-12
Completion: 2008-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Granisetron	Other / unclassified	—	Intravenous
Subject	Ramosetron	Small molecule	—	Intravenous

Indications

No indication recorded.